Loading
A phase 3 trial in lung cancer, run by Anhui Shi, MD, not yet recruiting.
Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) is a phase 3, randomised interventional study registered as NCT06719336 by Anhui Shi, MD, with a registry enrolment figure of 182 participants, started 2024-12-16 and due to reach its primary completion in 2028-12-16. Interventions recorded: High-dose Hyperfractionated Simultaneous Integrated Boost Radiotherapy; atezolizumab or durvalumab. Conditions listed: Extensive-stage Small Cell Lung Cancer. Primary outcome: Overall survival (OS). Lung eligibility wording from the registry: "Confirmed Extensive Stage Small Cell Lung Cancer (ES-SCLC)". No results are recorded here; the registry entry is the source.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.